ASTANA, Kazakhstan, November 1. Kazakhstan and France signed an agreement on production of foot-and-mouth disease (FMD) vaccine, Trend reports.
Thus, an agreement on cooperation, licenses and supplies between QazBioPharm JSC (national holding of Kazakhstan) and Boehringer Ingelheim Animal Health France for the local production of foot-and-mouth disease vaccine in Kazakhstan was signed in the presence of President of Kazakhstan Kassym-Jomart Tokayev and President of France Emmanuel Macron in Astana.
The QazBioPharm holding was created with 100 percent state participation in the authorized capital, and the right to own and use the state block of shares was transferred to the Ministry of Health of the Republic of Kazakhstan.
From January through August 2023, trade turnover between Kazakhstan and France amounted to $2.7 billion, which is 21.1 percent higher than for the same period in 2022 ($2.2 billion).
Exports from Kazakhstan to France from January through August 2023 increased by 2.9 percent and amounted to $1.8 billion. Imports to Kazakhstan from France from January through August 2023 amounted to $881.8 million.